These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19129258)

  • 1. Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy.
    Luo P; Zhou Y; Chang HH; Zhang J; Seki T; Wang CY; Inscho EW; Wang MH
    Am J Physiol Renal Physiol; 2009 Mar; 296(3):F556-63. PubMed ID: 19129258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier.
    McCarthy ET; Sharma R; Sharma M
    Kidney Int; 2005 Jan; 67(1):152-6. PubMed ID: 15610238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Alpina oxyphylla extract on streptozotocin-induced kidney injure via regulating TGF-β1 and MyD88.
    Wu JX; Jia A; Tan YF; Xu H; Tian JP; Wang Y; Li HL; Gao BM; Li YH
    BMC Complement Med Ther; 2020 Jul; 20(1):217. PubMed ID: 32660472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of 20-HETE/PPARs involved in reno-therapeutic effect of naringenin on diabetic nephropathy.
    Ding S; Qiu H; Huang J; Chen R; Zhang J; Huang B; Zou X; Cheng O; Jiang Q
    Chem Biol Interact; 2019 Jul; 307():116-124. PubMed ID: 31063766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats.
    Dahly-Vernon AJ; Sharma M; McCarthy ET; Savin VJ; Ledbetter SR; Roman RJ
    Hypertension; 2005 Apr; 45(4):643-8. PubMed ID: 15723968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide Improves Renal Injury in Diabetic Nephropathy Rats through TGF-β1/Smads Signal Pathway.
    Pang R; Gu D
    Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1905-1911. PubMed ID: 34530721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway.
    Eid S; Maalouf R; Jaffa AA; Nassif J; Hamdy A; Rashid A; Ziyadeh FN; Eid AA
    PLoS One; 2013; 8(8):e70029. PubMed ID: 23936373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy.
    Eid S; Abou-Kheir W; Sabra R; Daoud G; Jaffa A; Ziyadeh FN; Roman L; Eid AA
    J Biol Regul Homeost Agents; 2013; 27(3):693-703. PubMed ID: 24152838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
    Zuo Y; Gu Y; Ma J; Lin S
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.
    Yuan J; Jia R; Bao Y
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):118-26. PubMed ID: 17907099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells.
    Kim SI; Han DC; Lee HB
    J Am Soc Nephrol; 2000 Jan; 11(1):80-87. PubMed ID: 10616843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels.
    Katary MM; Pye C; Elmarakby AA
    Prostaglandins Other Lipid Mediat; 2017 Sep; 132():3-11. PubMed ID: 27596333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats.
    Huang H; Jiang Y; Mao G; Yuan F; Zheng H; Ruan Y; Wu T
    J Sci Food Agric; 2017 Mar; 97(4):1359-1366. PubMed ID: 27363537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism.
    Zhou S; Zhao P; Li Y; Deng T; Tian L; Li H
    Eur J Pharmacol; 2014 Oct; 740():9-14. PubMed ID: 25008071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
    Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of renal 20-hydroxyeicosatetraenoic acid by clofibrate attenuates high-fat diet-induced hypertension in rats.
    Zhou Y; Huang H; Chang HH; Du J; Wu JF; Wang CY; Wang MH
    J Pharmacol Exp Ther; 2006 Apr; 317(1):11-8. PubMed ID: 16339392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment.
    Roy S; Dontamalla SK; Mondru AK; Sannigrahi S; Veerareddy PR
    Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney involvement in a nongenetic rat model of type 2 diabetes.
    Danda RS; Habiba NM; Rincon-Choles H; Bhandari BK; Barnes JL; Abboud HE; Pergola PE
    Kidney Int; 2005 Dec; 68(6):2562-71. PubMed ID: 16316331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of catalpol on diabetic nephropathy in rats.
    Dong Z; Chen CX
    Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth factor-β1-connective tissue growth factor signalling cascade.
    Huang J; Matavelli LC; Siragy HM
    Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):215-21. PubMed ID: 21265872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.